NGNENeurogene Inc.
$26.44+13% 1Y
$26.44
$16.3752 weeks$42.88
The financials
Neurogene Inc. by the numbers
For the full year FY2025, revenue was $0 (−100% year on year) and net income −$90M. The next results filing is expected around Nov 12, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | n/a | $0 | n/a |
| Operating income | −$37M | −$26M | n/a |
| Net income | −$34M | −$22M | n/a |
| Diluted EPS | −$1.53 | −$1.05 | n/a |